Answers are grounded in this paper and cite their sources.
Triphenyl phosphate (TPHP) is an emerging organophosphate ester contaminant associated with adverse health effects, yet immunoassay-based methods for its rapid screening remain unavailable. Rabbit monoclonal antibodies (RmAbs) are attractive recognition elements for small-molecule immunoassays, but efficient strategies for generating small-molecule-specific RmAbs are still limited. Here, we developed a single-B-cell-based two-step screening (SCTS) strategy to generate RmAbs against TPHP. The workflow combined dual fluorescence-activated cell sorting for enrichment of hapten−specific B cells with icELISA-based screening of culture supernatants to identify antibodies recognizing free TPHP. From cell sorting to functional validation, the process was completed within 7 days. Using this strategy, three RmAbs were obtained, with icELISA half-maximal inhibitory concentration (IC50) values of 0.021−0.055 ng/mL. Compared with the mouse monoclonal antibodies evaluated in this study, the RmAbs exhibited higher sensitivity and specificity, together with greater tolerance to heat, pH, ionic strength, and acetonitrile. Molecular docking suggested that the improved performance may be associated with the extended CDR-H3 of RmAb3B11, which formed a deeper and more restrictive binding cavity with higher shape complementarity and stronger steric discrimination toward TPHP. Based on RmAb3B11, a lateral flow immunoassay (LFIA) was established for rapid on-site detection of TPHP, with visual detection limits of 0.2 ng/mL in river water, 1.0 ng/g in dust, and 0.8 ng/mL in raw and packaged milk. Analysis of 40 blind samples showed good agreement between LFIA and UPLC−MS/MS results, supporting the accuracy and reliability of the method.
No takes yet. Share an insight, caveat, or question.
He et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: